The origin of unwanted editing byproducts in gene editing
The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
The rapid development of CRISPR-Cas genome editing tools has greatly changed the way to conduct research and holds tremendous promise for clinical applications. During genome editing, CRISPR-Cas enzymes induce DNA breaks at the target sites and subsequently the DNA repair pathways are recruited to generate diverse editing outcomes. Besides off-target cleavage, unwanted editing outcomes including chromosomal structural variations and exogenous DNA integrations have recently raised concerns for clinical safety. To eliminate these unwanted editing byproducts, we need to explore the underlying mechanisms for the formation of diverse editing outcomes from the perspective of DNA repair. Here, we describe the involved DNA repair pathways in sealing Cas enzyme-induced DNA double-stranded breaks and discuss the origins and effects of unwanted editing byproducts on genome stability. Furthermore, we propose the potential risk of inhibiting DNA repair pathways to enhance gene editing. The recent combined studies of DNA repair and CRISPR-Cas editing provide a framework for further optimizing genome editing to enhance editing safety.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The random fusion of many broken sites can cause chromosomal rearrangement, inducing structural variations, including chromosome translocation, deletion, and inversion, and eliciting cellular lesions.416”
From p53: from understanding its structure to advances in therapeutic targeting (2026) · cites this paper as [416]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia
Frangoul, H., Altshuler, D., Cappellini, M. D., Chen, Y.-S., Domm, J., Eustace, B. K., Foell, J., de la Fuente, J., Grupp, S., Handgretinger, R., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2031054 · Cited by 1,962 · cited 1×
“These CRISPRbased therapeutic schemes target some very intractable diseases, including T cell, chimeric antigen receptor T cell (CAR T), or T cell receptor-engineered T cell (TCR T) therapy for acquired immunodeficiency syndrome (AIDS) and malignancy [17–19], modified hematopoietic stem and progenitor cells (HSPCs) fo…”
BackgroundNon-homologous DNA end joining and alternative pathways to double-strand break repair
Chang, H. H. Y., Pannunzio, N. R., Adachi, N., & Lieber, M. R. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.48 · Cited by 1,757
Evolved Cas9 variants with broad PAM compatibility and high DNA specificity
Hu, J. H., Miller, S. M., Geurts, M. H., Tang, W., Chen, L., Sun, N., Zeina, C. M., Gao, X., Rees, H. A., Lin, Z., et al. (2018) · Nature · doi:10.1038/nature26155 · Cited by 1,552
Self-citationCRISPR-engineered T cells in patients with refractory cancer
Stadtmauer, E. A., Fraietta, J. A., Davis, M. M., Cohen, A. D., Weber, K. L., Lancaster, E., Mangan, P. A., Kulikovskaya, I., Gupta, M., Chen, F., et al. (2020) · Science · doi:10.1126/science.aba7365 · Cited by 1,478 · cited 2×
“Quantitative RT-PCR has been widely used to detect chromosomal translocations between two target sites [18,198,205], but the resolution is very limited.”
BackgroundMethodEndogenous DNA damage as a source of genomic instability in cancer
Tubbs, A., & Nussenzweig, A. (2017) · Cell · doi:10.1016/j.cell.2017.01.002 · Cited by 1,452
Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems
Nishida, K., Arazoe, T., Yachie, N., Banno, S., Kakimoto, M., Tabata, M., Mochizuki, M., Miyabe, A., Araki, M., Hara, K. Y., et al. (2016) · Science · doi:10.1126/science.aaf8729 · Cited by 1,349
Enhanced proofreading governs CRISPR-Cas9 targeting accuracy
Chen, J. S., Dagdas, Y. S., Kleinstiver, B. P., Welch, M. M., Sousa, A. A., Harrington, L. B., Sternberg, S. H., Joung, J. K., Yildiz, A., & Doudna, J. A. (2017) · Nature · doi:10.1038/nature24268 · Cited by 1,168
Ma, Y., Pannicke, U., Schwarz, K., & Lieber, M. R. (2002) · Cell · doi:10.1016/s0092-8674(02)00671-2 · Cited by 1,166
In vivo genome editing via CRISPR/Cas9 mediated homology-independent targeted integration
Suzuki, K., Tsunekawa, Y., Hernandez-Benitez, R., Wu, J., Zhu, J., Kim, E. J., Hatanaka, F., Yamamoto, M., Araoka, T., Li, Z., et al. (2016) · Nature · doi:10.1038/nature20565 · Cited by 1,150
Maruyama, T., Dougan, S. K., Truttmann, M. C., Bilate, A. M., Ingram, J. R., & Ploegh, H. L. (2015) · Nature Biotechnology · doi:10.1038/nbt.3190 · Cited by 1,137
Richardson, C. D., Ray, G. J., DeWitt, M. A., Curie, G. L., & Corn, J. E. (2016) · Nature Biotechnology · doi:10.1038/nbt.3481 · Cited by 1,098
In vivo gene editing in dystrophic mouse muscle and muscle stem cells
Tabebordbar, M., Zhu, K., Cheng, J. K. W., Chew, W. L., Widrick, J. J., Yan, W. X., Maesner, C., Wu, E. Y., Xiao, R., Ran, F. A., et al. (2016) · Science · doi:10.1126/science.aad5177 · Cited by 1,046
Digenome-seq: Genome-wide profiling of CRISPR-cas9 off-target effects in human cells
Kim, D., Bae, S., Park, J., Kim, E., Kim, S., Yu, H. R., Hwang, J., Kim, J.-I., & Kim, J.-S. (2015) · Nature Methods · doi:10.1038/nmeth.3284 · Cited by 992
Multiplex genome editing to generate universal CAR T cells resistant to PD1 inhibition
Ren, J., Liu, X., Fang, C., Jiang, S., June, C. H., & Zhao, Y. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-1300 · Cited by 942
CIRCLE-Seq: A highly sensitive in vitro screen for genome-wide CRISPR-cas9 nuclease off-targets
Tsai, S. Q., Nguyen, N. T., Malagon-Lopez, J., Topkar, V. V., Aryee, M. J., & Joung, J. K. (2017) · Nature Methods · doi:10.1038/nmeth.4278 · Cited by 814
Vakulskas, C. A., Dever, D. P., Rettig, G. R., Turk, R., Jacobi, A. M., Collingwood, M. A., Bode, N. M., McNeill, M. S., Yan, S., Camarena, J., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0137-0 · Cited by 782
Cytosine base editor generates substantial off-target single-nucleotide variants in mouse embryos
Zuo, E., Sun, Y., Wei, W., Yuan, T., Ying, W., Sun, H., Yuan, L., Steinmetz, L. M., Li, Y., & Yang, H. (2019) · Science · doi:10.1126/science.aav9973 · Cited by 782 · cited 1×
“Whole-genome sequencing or exon sequencing have also been used to identify chromosomal structural variations [78,206], but these methods are costly and difficult to analyze.”
MethodGenome-wide analysis reveals characteristics of off-target sites bound by the Cas9 endonuclease
Kuscu, C., Arslan, S., Singh, R., Thorpe, J., & Adli, M. (2014) · Nature Biotechnology · doi:10.1038/nbt.2916 · Cited by 777 · cited 1×
“Off-target activities Off-target sites of CRISPR-Cas9 are highly homologous to the target sites with higher mutation tolerance at the PAM-distal region [182].”
BackgroundBuck, D., Malivert, L., de Chasseval, R., Barraud, A., Fondanèche, M.-C., Sanal, O., Plebani, A., Stéphan, J.-L., Hufnagel, M., le Deist, F., et al. (2006) · Cell · doi:10.1016/j.cell.2005.12.030 · Cited by 722
Prevention of muscular dystrophy in mice by CRISPR/Cas9–mediated editing of germline DNA
Long, C., McAnally, J. R., Shelton, J. M., Mireault, A. A., Bassel-Duby, R., & Olson, E. N. (2014) · Science · doi:10.1126/science.1254445 · Cited by 720
Endogenous DNA double-strand breaks: production, fidelity of repair, and induction of cancer
Vilenchik, M. M., & Knudson, A. G. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2135498100 · Cited by 717
In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni
Kim, E., Koo, T., Park, S. W., Kim, D., Kim, K., Cho, H.-Y., Song, D. W., Lee, K. J., Jung, M. H., Kim, S., et al. (2017) · Nature Communications · doi:10.1038/ncomms14500 · Cited by 715
Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10
Maeder, M. L., Stefanidakis, M., Wilson, C. J., Baral, R., Barrera, L. A., Bounoutas, G. S., Bumcrot, D., Chao, H., Ciulla, D. M., DaSilva, J. A., et al. (2019) · Nature Medicine · doi:10.1038/s41591-018-0327-9 · Cited by 707
Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis
Hou, Z., Zhang, Y., Propson, N. E., Howden, S. E., Chu, L.-F., Sontheimer, E. J., & Thomson, J. A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1313587110 · Cited by 681
Genome-wide detection of DNA double-stranded breaks induced by engineered nucleases
Frock, R. L., Hu, J., Meyers, R. M., Ho, Y.-J., Kii, E., & Alt, F. W. (2015) · Nature Biotechnology · doi:10.1038/nbt.3101 · Cited by 673
Cytosine, but not adenine, base editors induce genome-wide off-target mutations in rice
Jin, S., Zong, Y., Gao, Q., Zhu, Z., Wang, Y., Qin, P., Liang, C., Wang, D., Qiu, J.-L., Zhang, F., et al. (2019) · Science · doi:10.1126/science.aaw7166 · Cited by 665
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors
Grünewald, J., Zhou, R., Garcia, S. P., Iyer, S., Lareau, C. A., Aryee, M. J., & Joung, J. K. (2019) · Nature · doi:10.1038/s41586-019-1161-z · Cited by 663
Poirot, L., Philip, B., Schiffer-Mannioui, C., Le Clerre, D., Chion-Sotinel, I., Derniame, S., Potrel, P., Bas, C., Lemaire, L., Galetto, R., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3321 · Cited by 605
Predictable and precise template-free CRISPR editing of pathogenic variants
Shen, M. W., Arbab, M., Hsu, J. Y., Worstell, D., Culbertson, S. J., Krabbe, O., Cassa, C. A., Liu, D. R., Gifford, D. K., & Sherwood, R. I. (2018) · Nature · doi:10.1038/s41586-018-0686-x · Cited by 569 · cited 1×
“MMEJ-mediated deletions are relatively predictable in the context of embedded microhomology in local sequence [61,62,64,127,128].”
BackgroundGene editing restores dystrophin expression in a canine model of Duchenne muscular dystrophy
Amoasii, L., Hildyard, J. C. W., Li, H., Sanchez-Ortiz, E., Mireault, A., Caballero, D., Harron, R., Stathopoulou, T.-R., Massey, C., Shelton, J. M., et al. (2018) · Science · doi:10.1126/science.aau1549 · Cited by 546
Directed evolution of CRISPR-Cas9 to increase its specificity
Lee, J. K., Jeong, E., Lee, J., Jung, M., Shin, E., Kim, Y.-H., Lee, K., Jung, I., Kim, D., Kim, S., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05477-x · Cited by 525
Highly efficient therapeutic gene editing of human hematopoietic stem cells
Wu, Y., Zeng, J., Roscoe, B. P., Liu, P., Yao, Q., Lazzarotto, C. R., Clement, K., Cole, M. A., Luk, K., Baricordi, C., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0401-y · Cited by 515 · cited 1×
“These CRISPRbased therapeutic schemes target some very intractable diseases, including T cell, chimeric antigen receptor T cell (CAR T), or T cell receptor-engineered T cell (TCR T) therapy for acquired immunodeficiency syndrome (AIDS) and malignancy [17–19], modified hematopoietic stem and progenitor cells (HSPCs) fo…”
BackgroundA highly specific SpCas9 variant is identified by in vivo screening in yeast
Casini, A., Olivieri, M., Petris, G., Montagna, C., Reginato, G., Maule, G., Lorenzin, F., Prandi, D., Romanel, A., Demichelis, F., et al. (2018) · Nature Biotechnology · doi:10.1038/nbt.4066 · Cited by 493 · cited 1×
“Sniper-Cas9, evo-Cas9, and xCas9 were developed by high-throughput screening methods [174,176,186].”
BackgroundCRISPR-Cas9 genome editing induces megabase-scale chromosomal truncations
Cullot, G., Boutin, J., Toutain, J., Prat, F., Pennamen, P., Rooryck, C., Teichmann, M., Rousseau, E., Lamrissi-Garcia, I., Guyonnet-Duperat, V., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09006-2 · Cited by 474 · cited 1×
“5 Mb deletion was also identified at the UROS loci in HEK293T cells [42].”
BackgroundCRISPR-Edited Stem Cells in a Patient with HIV and Acute Lymphocytic Leukemia
Xu, L., Wang, J., Liu, Y., Xie, L., Su, B., Mou, D., Wang, L., Liu, T., Wang, X., Zhang, B., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1817426 · Cited by 454
Mapping the genomic landscape of CRISPR-Cas9 cleavage
Cameron, P., Fuller, C. K., Donohoue, P. D., Jones, B. N., Thompson, M. S., Carter, M. M., Gradia, S., Vidal, B., Garner, E., Slorach, E. M., et al. (2017) · Nature Methods · doi:10.1038/nmeth.4284 · Cited by 443
Unbiased detection of CRISPR off-targets in vivo using DISCOVER-Seq
Wienert, B., Wyman, S. K., Richardson, C. D., Yeh, C. D., Akcakaya, P., Porritt, M. J., Morlock, M., Vu, J. T., Kazane, K. R., Watry, H. L., et al. (2019) · Science · doi:10.1126/science.aav9023 · Cited by 434 · cited 1×
“These methods have been summarized very well in previous literature [28,35,38].”
MethodHigh levels of AAV vector integration into CRISPR-induced DNA breaks
Hanlon, K. S., Kleinstiver, B. P., Garcia, S. P., Zaborowski, M. P., Volak, A., Spirig, S. E., Muller, A., Sousa, A. A., Tsai, S. Q., Bengtsson, N. E., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12449-2 · Cited by 431
Long Neural Genes Harbor Recurrent DNA Break Clusters in Neural Stem/Progenitor Cells
Wei, P.-C., Chang, A. N., Kao, J., Du, Z., Meyers, R. M., Alt, F. W., & Schwer, B. (2016) · Cell · doi:10.1016/j.cell.2015.12.039 · Cited by 280
A compact, high-accuracy Cas9 with a dinucleotide PAM for in vivo genome editing
Edraki, A., Mir, A., Ibraheim, R., Gainetdinov, I., Yoon, Y., Song, C.-Q., Cao, Y., Gallant, J., Xue, W., Rivera-Pérez, J. A., et al. (2019) · Molecular Cell · doi:10.1016/j.molcel.2018.12.003 · Cited by 265
Streptococcus thermophilus CRISPR-cas9 systems enable specific editing of the human genome
Müller, M., Lee, C. M., Gasiunas, G., Davis, T. H., Cradick, T. J., Siksnys, V., Bao, G., Cathomen, T., & Mussolino, C. (2016) · Molecular Therapy · doi:10.1038/mt.2015.218 · Cited by 254
Chen, W., McKenna, A., Schreiber, J., Haeussler, M., Yin, Y., Agarwal, V., Noble, W. S., & Shendure, J. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz487 · Cited by 216
A Thermostable Cas9 with Increased Lifetime in Human Plasma
Harrington, L. B., Paez-Espino, D., Staahl, B. T., Chen, J. S., Ma, E., Kyrpides, N. C., & Doudna, J. A. (2017) · Nature Communications · doi:10.1038/s41467-017-01408-4 · Cited by 205
Highly Parallel Profiling of Cas9 Variant Specificity
Schmid-Burgk, J. L., Gao, L., Li, D., Gardner, Z., Strecker, J., Lash, B., & Zhang, F. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.02.023 · Cited by 197
Evaluating and enhancing target specificity of gene-editing nucleases and deaminases
Kim, D., Luk, K., Wolfe, S. A., & Kim, J.-S. (2019) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-013118-111730 · Cited by 171
Rationally designed APOBEC3B cytosine base editors with improved specificity
Jin, S., Fei, H., Zhu, Z., Luo, Y., Liu, J., Gao, S., Zhang, F., Chen, Y.-H., Wang, Y., & Gao, C. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.07.005 · Cited by 159
Microhomologies are prevalent at Cas9-induced larger deletions
Owens, D. D. G., Caulder, A., Frontera, V., Harman, J. R., Allan, A. J., Bucakci, A., Greder, L., Codner, G. F., Hublitz, P., McHugh, P. J., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz459 · Cited by 136
DIG-Seq: A genome-wide CRISPR off-target profiling method using chromatin DNA
Kim, D., & Kim, J.-S. (2018) · Genome Research · doi:10.1101/gr.236620.118 · Cited by 108
Detect-seq reveals out-of-protospacer editing and target-strand editing by cytosine base editors
Lei, Z., Meng, H., Lv, Z., Liu, M., Zhao, H., Wu, H., Zhang, X., Liu, L., Zhuang, Y., Yin, K., et al. (2021) · Nature Methods · doi:10.1038/s41592-021-01172-w · Cited by 67
Research works printed but not linked: 166
- Cho SW, Kim S, Kim JM, Kim JS. Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease. Nat Biotechnol, 2013, 230-232. · DOI · Paper page
- Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, Hsu PD. Multiplex genome engineering using CRISPR/Cas systems. Science, 2013, 819-823. · DOI · Paper page
- Jinek M, East A, Cheng A, Lin S, Ma E, Doudna J. RNA-programmed genome editing in human cells. eLife, 2013, · DOI · Paper page
- Mali P, Yang L, Esvelt KM, Aach J, Guell M, DiCarlo JE, Norville JE. RNA-guided human genome engineering via Cas9. Science, 2013, 823-826. · DOI · Paper page
- Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E. A programmable dual-RNA–guided DNA endonuclease in adaptive bacterial immunity. Science, 2012, 816-821. · DOI · Paper page
- Zetsche B, Gootenberg JS, Abudayyeh OO, Slaymaker IM, Makarova KS, Essletzbichler P, Volz SE. Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system. Cell, 2015, 759-771. · DOI · Paper page
- Liu JJ, Orlova N, Oakes BL, Ma E, Spinner HB, Baney KLM, Chuck J. CasX enzymes comprise a distinct family of RNA-guided genome editors. Nature, 2019, 218-223. · DOI · Paper page
- Kim DY, Lee JM, Moon SB, Chin HJ, Park S, Lim Y, Kim D. Efficient CRISPR editing with a hypercompact Cas12f1 and engineered guide RNAs delivered by adeno-associated virus. Nat Biotechnol, 2021, 94-102. · DOI · Paper page
- Wu Z, Zhang Y, Yu H, Pan D, Wang Y, Wang Y, Li F. Programmed genome editing by a miniature CRISPR-Cas12f nuclease. Nat Chem Biol, 2021, 1132-1138. · DOI · Paper page
- Xu X, Chemparathy A, Zeng L, Kempton HR, Shang S, Nakamura M, Qi LS. Engineered miniature CRISPR-Cas system for mammalian genome regulation and editing. Mol Cell, 2021, 4333-4345. · DOI · Paper page
- Komor AC, Kim YB, Packer MS, Zuris JA, Liu DR. Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature, 2016, 420-424. · DOI · Paper page
- Gaudelli NM, Komor AC, Rees HA, Packer MS, Badran AH, Bryson DI, Liu DR. Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage. Nature, 2017, 464-471. · DOI · Paper page
- Zhao D, Li J, Li S, Xin X, Hu M, Price MA, Rosser SJ. Glycosylase base editors enable C-to-A and C-to-G base changes. Nat Biotechnol, 2021, 35-40. · DOI · Paper page
- Anzalone AV, Randolph PB, Davis JR, Sousa AA, Koblan LW, Levy JM, Chen PJ. Search-and-replace genome editing without double-strand breaks or donor DNA. Nature, 2019, 149-157. · DOI · Paper page
- Cox DBT, Gootenberg JS, Abudayyeh OO, Franklin B, Kellner MJ, Joung J, Zhang F. RNA editing with CRISPR-cas13. Science, 2017, 1019-1027. · DOI · Paper page
- Qu L, Yi Z, Zhu S, Wang C, Cao Z, Zhou Z, Yuan P. Programmable RNA editing by recruiting endogenous ADAR using engineered RNAs. Nat Biotechnol, 2019, 1059-1069. · DOI · Paper page
- Lu Y, Xue J, Deng T, Zhou X, Yu K, Deng L, Huang M. Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer. Nat Med, 2020, 732-740. · DOI · Paper page
- Moretti A, Fonteyne L, Giesert F, Hoppmann P, Meier AB, Bozoglu T, Baehr A. Somatic gene editing ameliorates skeletal and cardiac muscle failure in pig and human models of Duchenne muscular dystrophy. Nat Med, 2020, 207-214. · DOI · Paper page
- Saha K, Sontheimer EJ, Brooks PJ, Dwinell MR, Gersbach CA, Liu DR, Murray SA. The NIH somatic cell genome editing program. Nature, 2021, 195-204. · DOI · Paper page
- Anzalone AV, Koblan LW, Liu DR. Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors. Nat Biotechnol, 2020, 824-844. · DOI · Paper page
- Zhang F. Development of CRISPR-Cas systems for genome editing and beyond. Quart Rev Biophys, 2019, · DOI · Paper page
- Bae S, Park J, Kim JS. Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases. Bioinformatics, 2014, 1473-1475. · DOI · Paper page
- Turchiano G, Andrieux G, Klermund J, Blattner G, Pennucci V, El Gaz M, Monaco G. Quantitative evaluation of chromosomal rearrangements in gene-edited human stem cells by CAST-Seq. Cell Stem Cell, 2021, 1136-1147.e5. · DOI · Paper page
- Tsai SQ, Zheng Z, Nguyen NT, Liebers M, Topkar VV, Thapar V, Wyvekens N. GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases. Nat Biotechnol, 2015, 187-197. · DOI · Paper page
- Yin J, Liu M, Liu Y, Wu J, Gan T, Zhang W, Li Y. Optimizing genome editing strategy by primer-extension-mediated sequencing. Cell Discov, 2019, · DOI · Paper page
- Giannoukos G, Ciulla DM, Marco E, Abdulkerim HS, Barrera LA, Bothmer A, Dhanapal V. UDiTaS™, a genome editing detection method for indels and genome rearrangements. BMC Genomics, 2018, · DOI · Paper page
- Kosicki M, Tomberg K, Bradley A. Repair of double-strand breaks induced by CRISPR–Cas9 leads to large deletions and complex rearrangements. Nat Biotechnol, 2018, 765-771. · DOI · Paper page
- Liu M, Zhang W, Xin C, Yin J, Shang Y, Ai C, Li J. Global detection of DNA repair outcomes induced by CRISPR–Cas9. Nucleic Acids Res, 2021, 8732-8742. · DOI
- Zhang W, Yin J, Zhang-Ding Z, Xin C, Liu M, Wang Y, Ai C. In-depth assessment of the PAM compatibility and editing activities of Cas9 variants. Nucleic Acids Res, 2021, 8785-8795. · DOI · Paper page
- Adikusuma F, Piltz S, Corbett MA, Turvey M, McColl SR, Helbig KJ, Beard MR. Large deletions induced by Cas9 cleavage. Nature, 2018, E8-E9. · DOI · Paper page
- Makarova KS, Wolf YI, Alkhnbashi OS, Costa F, Shah SA, Saunders SJ, Barrangou R. An updated evolutionary classification of CRISPR–Cas systems. Nat Rev Microbiol, 2015, 722-736. · DOI · Paper page
- Shmakov S, Abudayyeh OO, Makarova KS, Wolf YI, Gootenberg JS, Semenova E, Minakhin L. Discovery and functional characterization of diverse class 2 CRISPR-Cas systems. Mol Cell, 2015, 385-397. · DOI · Paper page
- Makarova KS, Wolf YI, Iranzo J, Shmakov SA, Alkhnbashi OS, Brouns SJJ, Charpentier E. Evolutionary classification of CRISPR–Cas systems: a burst of class 2 and derived variants. Nat Rev Microbiol, 2020, 67-83. · DOI · Paper page
- Hwang WY, Fu Y, Reyon D, Maeder ML, Tsai SQ, Sander JD, Peterson RT. Efficient genome editing in zebrafish using a CRISPR-Cas system. Nat Biotechnol, 2013, 227-229. · DOI · Paper page
- Ran FA, Cong L, Yan WX, Scott DA, Gootenberg JS, Kriz AJ, Zetsche B. In vivo genome editing using Staphylococcus aureus Cas9. Nature, 2015, 186-191. · DOI · Paper page
- Chatterjee P, Jakimo N, Jacobson JM. Minimal PAM specificity of a highly similar SpCas9 ortholog. Sci Adv, 2018, · DOI · Paper page
- Hirano H, Gootenberg JS, Horii T, Abudayyeh OO, Kimura M, Hsu PD, Nakane T. Structure and engineering of Francisella novicida Cas9. Cell, 2016, 950-961. · DOI · Paper page
- Deltcheva E, Chylinski K, Sharma CM, Gonzales K, Chao Y, Pirzada ZA, Eckert MR. CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature, 2011, 602-607. · DOI · Paper page
- Sternberg SH, Redding S, Jinek M, Greene EC, Doudna JA. DNA interrogation by the CRISPR RNA-guided endonuclease Cas9. Nature, 2014, 62-67. · DOI · Paper page
- Szczelkun MD, Tikhomirova MS, Sinkunas T, Gasiunas G, Karvelis T, Pschera P, Siksnys V. Direct observation of R-loop formation by single RNA-guided Cas9 and Cascade effector complexes. Proc Natl Acad Sci USA, 2014, 9798-9803. · DOI · Paper page
- Allen F, Crepaldi L, Alsinet C, Strong AJ, Kleshchevnikov V, De Angeli P, Páleníková P. Predicting the mutations generated by repair of Cas9-induced double-strand breaks. Nat Biotechnol, 2018, 64-72. · DOI · Paper page
- Shou J, Li J, Liu Y, Wu Q. Precise and predictable CRISPR chromosomal rearrangements reveal principles of Cas9-mediated nucleotide insertion. Mol Cell, 2018, 498-509.e4. · DOI · Paper page
- Chakrabarti AM, Henser-Brownhill T, Monserrat J, Poetsch AR, Luscombe NM, Scaffidi P. Target-specific precision of CRISPR-mediated genome editing. Mol Cell, 2019, 699-713.e6. · DOI · Paper page
- Ran FA, Hsu PD, Lin CY, Gootenberg JS, Konermann S, Trevino AE, Scott DA. Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell, 2013, 1380-1389. · DOI · Paper page
- Qi LS, Larson MH, Gilbert LA, Doudna JA, Weissman JS, Arkin AP, Lim WA. Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell, 2013, 1173-1183. · DOI · Paper page
- Brinkman EK, Chen T, de Haas M, Holland HA, Akhtar W, van Steensel B. Kinetics and fidelity of the repair of Cas9-induced double-strand DNA breaks. Mol Cell, 2018, 801-813.e6. · DOI · Paper page
- Yamano T, Nishimasu H, Zetsche B, Hirano H, Slaymaker IM, Li Y, Fedorova I. Crystal structure of cpf1 in complex with guide RNA and target DNA. Cell, 2016, 949-962. · DOI · Paper page
- Gehrke JM, Cervantes O, Clement MK, Wu Y, Zeng J, Bauer DE, Pinello L. An APOBEC3A-Cas9 base editor with minimized bystander and off-target activities. Nat Biotechnol, 2018, 977-982. · DOI · Paper page
- Li C, Zhang R, Meng X, Chen S, Zong Y, Lu C, Qiu JL. Targeted, random mutagenesis of plant genes with dual cytosine and adenine base editors. Nat Biotechnol, 2020, 875-882. · DOI · Paper page
- Grünewald J, Zhou R, Lareau CA, Garcia SP, Iyer S, Miller BR, Langner LM. A dual-deaminase CRISPR base editor enables concurrent adenine and cytosine editing. Nat Biotechnol, 2020, 861-864. · DOI · Paper page
- Zhang X, Zhu B, Chen L, Xie L, Yu W, Wang Y, Li L. Dual base editor catalyzes both cytosine and adenine base conversions in human cells. Nat Biotechnol, 2020, 856-860. · DOI · Paper page
- Zhou C, Sun Y, Yan R, Liu Y, Zuo E, Gu C, Han L. Off-target RNA mutation induced by DNA base editing and its elimination by mutagenesis. Nature, 2019, 275-278. · DOI · Paper page
- Alt FW, Zhang Y, Meng FL, Guo C, Schwer B. Mechanisms of programmed DNA lesions and genomic instability in the immune system. Cell, 2013, 417-429. · DOI · Paper page
- Nussenzweig A, Nussenzweig MC. Origin of chromosomal translocations in lymphoid cancer. Cell, 2010, 27-38. · DOI · Paper page
- Lieber MR. Mechanisms of human lymphoid chromosomal translocations. Nat Rev Cancer, 2016, 387-398. · DOI · Paper page
- Casellas R, Basu U, Yewdell WT, Chaudhuri J, Robbiani DF, Di Noia JM. Mutations, kataegis and translocations in B cells: understanding AID promiscuous activity. Nat Rev Immunol, 2016, 164-176. · DOI · Paper page
- Ciccia A, Elledge SJ. The DNA damage response: making it safe to play with knives. Mol Cell, 2010, 179-204. · DOI · Paper page
- Malkova A, Haber JE. Mutations arising during repair of chromosome breaks. Annu Rev Genet, 2012, 455-473. · DOI · Paper page
- Panier S, Boulton SJ. Double-strand break repair: 53BP1 comes into focus. Nat Rev Mol Cell Biol, 2014, 7-18. · DOI · Paper page
- Symington LS, Gautier J. Double-strand break end resection and repair pathway choice. Annu Rev Genet, 2011, 247-271. · DOI · Paper page
- Scully R, Panday A, Elango R, Willis NA. DNA double-strand break repair-pathway choice in somatic mammalian cells. Nat Rev Mol Cell Biol, 2019, 698-714. · DOI · Paper page
- Liu T, Huang J. Quality control of homologous recombination. Cell Mol Life Sci, 2014, 3779-3797. · DOI
- Chapman JR, Taylor MRG, Boulton SJ. Playing the end game: DNA double-strand break repair pathway choice. Mol Cell, 2012, 497-510. · DOI · Paper page
- Lieber MR. The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway. Annu Rev Biochem, 2010, 181-211. · DOI · Paper page
- Yang L, Guell M, Byrne S, Yang JL, De Los Angeles A, Mali P, Aach J. Optimization of scarless human stem cell genome editing. Nucleic Acids Res, 2013, 9049-9061. · DOI · Paper page
- Hollywood JA, Lee CM, Scallan MF, Harrison PT. Analysis of gene repair tracts from Cas9/gRNA double-stranded breaks in the human CFTR gene. Sci Rep, 2016, · DOI · Paper page
- Guo T, Feng YL, Xiao JJ, Liu Q, Sun XN, Xiang JF, Kong N. Harnessing accurate non-homologous end joining for efficient precise deletion in CRISPR/Cas9-mediated genome editing. Genome Biol, 2018, · DOI · Paper page
- Song B, Yang S, Hwang GH, Yu J, Bae S. Analysis of NHEJ-based DNA repair after CRISPR-mediated DNA cleavage. Int J Mol Sci, 2021, · DOI · Paper page
- Spagnolo L, Rivera-Calzada A, Pearl LH, Llorca O. Three-dimensional structure of the human DNA-PKcs/Ku70/Ku80 complex assembled on DNA and its implications for DNA DSB repair. Mol Cell, 2006, 511-519. · DOI · Paper page
- Griffith AJ, Blier PR, Mimori T, Hardin JA. Ku polypeptides synthesized in vitro assemble into complexes which recognize ends of double-stranded DNA. J Biol Chem, 1992, 331-338. · DOI · Paper page
- Walker JR, Corpina RA, Goldberg J. Structure of the Ku heterodimer bound to DNA and its implications for double-strand break repair. Nature, 2001, 607-614. · DOI · Paper page
- Gottlieb TM, Jackson SP. The DNA-dependent protein kinase: requirement for DNA ends and association with Ku antigen. Cell, 1993, 131-142. · DOI · Paper page
- Blier PR, Griffith AJ, Craft J, Hardin JA. Binding of Ku protein to DNA. Measurement of affinity for ends and demonstration of binding to nicks. J Biol Chem, 1993, 7594-7601. · DOI · Paper page
- Mimori T, Hardin JA. Mechanism of interaction between Ku protein and DNA. J Biol Chem, 1986, 10375-10379. · DOI · Paper page
- Ahnesorg P, Smith P, Jackson SP. XLF interacts with the XRCC4-DNA ligase IV complex to promote DNA nonhomologous end-joining. Cell, 2006, 301-313. · DOI · Paper page
- Grawunder U, Wilm M, Wu X, Kulesza P, Wilson TE, Mann M, Lieber MR. Activity of DNA ligase IV stimulated by complex formation with XRCC4 protein in mammalian cells. Nature, 1997, 492-495. · DOI · Paper page
- Xing M, Yang M, Huo W, Feng F, Wei L, Jiang W, Ning S. Interactome analysis identifies a new paralogue of XRCC4 in non-homologous end joining DNA repair pathway. Nat Commun, 2015, · DOI · Paper page
- Ochi T, Blackford AN, Coates J, Jhujh S, Mehmood S, Tamura N, Travers J. PAXX, a paralog of XRCC4 and XLF, interacts with Ku to promote DNA double-strand break repair. Science, 2015, 185-188. · DOI · Paper page
- Dai Y, Kysela B, Hanakahi LA, Manolis K, Riballo E, Stumm M, Harville TO. Nonhomologous end joining and V(D)J recombination require an additional factor. Proc Natl Acad Sci USA, 2003, 2462-2467. · DOI · Paper page
- Li Z, Otevrel T, Gao Y, Cheng HL, Seed B, Stamato TD, Taccioli GE. The XRCC4 gene encodes a novel protein involved in DNA double-strand break repair and V(D)J recombination. Cell, 1995, 1079-1089. · DOI · Paper page
- Wei YF, Robins P, Carter K, Caldecott K, Pappin DJ, Yu GL, Wang RP. Molecular cloning and expression of human cDNAs encoding a novel DNA ligase IV and DNA ligase III, an enzyme active in DNA repair and recombination. Mol Cell Biol, 1995, 3206-3216. · DOI · Paper page
- Li S, Kanno S, Watanabe R, Ogiwara H, Kohno T, Watanabe G, Yasui A. Polynucleotide kinase and aprataxin-like forkhead-associated protein (PALF) acts as both a single-stranded DNA endonuclease and a single-stranded DNA 3′ exonuclease and can participate in DNA end joining in a biochemical system. J Biol Chem, 2011, 36368-36377. · DOI · Paper page
- Kanno S, Kuzuoka H, Sasao S, Hong Z, Lan L, Nakajima S, Yasui A. A novel human AP endonuclease with conserved zinc-finger-like motifs involved in DNA strand break responses. EMBO J, 2007, 2094-2103. · DOI
- Bebenek K, Pedersen LC, Kunkel TA. Structure–function studies of DNA polymerase λ. Biochemistry, 2014, 2781-2792. · DOI · Paper page
- Aoufouchi S, Flatter E, Dahan A, Faili A, Bertocci B, Storck S, Delbos F. Two novel human and mouse DNA polymerases of the polX family. Nucleic Acids Res, 2000, 3684-3693. · DOI · Paper page
- Bertocci B, De Smet A, Weill JC, Reynaud CA. Nonoverlapping functions of DNA polymerases mu, lambda, and terminal deoxynucleotidyltransferase during immunoglobulin V(D)J recombination in vivo. Immunity, 2006, 31-41. · DOI · Paper page
- Quennet V, Beucher A, Barton O, Takeda S, Löbrich M. CtIP and MRN promote non-homologous end-joining of etoposide-induced DNA double-strand breaks in G1. Nucleic Acids Res, 2011, 2144-2152. · DOI · Paper page
- Nick McElhinny SA, Havener JM, Garcia-Diaz M, Juárez R, Bebenek K, Kee BL, Blanco L. A gradient of template dependence defines distinct biological roles for family X polymerases in nonhomologous end joining. Mol Cell, 2005, 357-366. · DOI · Paper page
- Čermák T, Curtin SJ, Gil-Humanes J, Čegan R, Kono TJY, Konečná E, Belanto JJ. A multipurpose toolkit to enable advanced genome engineering in plants. Plant Cell, 2017, 1196-1217. · DOI · Paper page
- Wu Y, Yuan Q, Zhu Y, Gao X, Song J, Yin Z. Improving FnCas12a genome editing by exonuclease fusion. CRISPR J, 2020, 503-511. · DOI
- Kabotyanski EB, Gomelsky L, Han JO, Stamato TD, Roth DB. Double-strand break repair in Ku86- and XRCC4-deficient cells. Nucleic Acids Res, 1998, 5333-5342. · DOI · Paper page
- Boulton SJ, Jackson SP. Saccharomyces cerevisiae Ku70 potentiates illegitimate DNA double-strand break repair and serves as a barrier to error-prone DNA repair pathways. EMBO J, 1996, 5093-5103. · DOI · Paper page
- Gu J, Lu H, Tippin B, Shimazaki N, Goodman MF, Lieber MR. XRCC4:DNA ligase IV can ligate incompatible DNA ends and can ligate across gaps. EMBO J, 2007, 1010-1023. · DOI · Paper page
- Bae S, Kweon J, Kim HS, Kim JS. Microhomology-based choice of Cas9 nuclease target sites. Nat Methods, 2014, 705-706. · DOI · Paper page
- Schep R, Brinkman EK, Leemans C, Vergara X, van der Weide RH, Morris B, van Schaik T. Impact of chromatin context on Cas9-induced DNA double-strand break repair pathway balance. Mol Cell, 2021, 2216-2230.e10. · DOI · Paper page
- Nakade S, Tsubota T, Sakane Y, Kume S, Sakamoto N, Obara M, Daimon T. Microhomology-mediated end-joining-dependent integration of donor DNA in cells and animals using TALENs and CRISPR/Cas9. Nat Commun, 2014, · DOI · Paper page
- Sakuma T, Nakade S, Sakane Y, Suzuki KIT, Yamamoto T. MMEJ-assisted gene knock-in using TALENs and CRISPR-Cas9 with the PITCh systems. Nat Protoc, 2016, 118-133. · DOI · Paper page
- Kim SI, Matsumoto T, Kagawa H, Nakamura M, Hirohata R, Ueno A, Ohishi M. Microhomology-assisted scarless genome editing in human iPSCs. Nat Commun, 2018, · DOI · Paper page
- Grajcarek J, Monlong J, Nishinaka-Arai Y, Nakamura M, Nagai M, Matsuo S, Lougheed D. Genome-wide microhomologies enable precise template-free editing of biologically relevant deletion mutations. Nat Commun, 2019, · DOI · Paper page
- Zhang WW, Matlashewski G. Single-strand annealing plays a major role in double-strand DNA break repair following CRISPR-cas9 cleavage in leishmania. mSphere, 2019, · DOI
- Truong LN, Li Y, Shi LZ, Hwang PYH, He J, Wang H, Razavian N. Microhomology-mediated end joining and homologous recombination share the initial end resection step to repair DNA double-strand breaks in mammalian cells. Proc Natl Acad Sci USA, 2013, 7720-7725. · DOI · Paper page
- Kent T, Chandramouly G, McDevitt SM, Ozdemir AY, Pomerantz RT. Mechanism of microhomology-mediated end-joining promoted by human DNA polymerase θ. Nat Struct Mol Biol, 2015, 230-237. · DOI · Paper page
- Mateos-Gomez PA, Gong F, Nair N, Miller KM, Lazzerini-Denchi E, Sfeir A. Mammalian polymerase θ promotes alternative NHEJ and suppresses recombination. Nature, 2015, 254-257. · DOI · Paper page
- Audebert M, Salles B, Calsou P. Involvement of poly(ADP-ribose) polymerase-1 and XRCC1/DNA ligase III in an alternative route for DNA double-strand breaks rejoining. J Biol Chem, 2004, 55117-55126. · DOI · Paper page
- Zhu Z, Chung WH, Shim EY, Lee SE, Ira G. Sgs1 helicase and two nucleases Dna2 and Exo1 resect DNA double-strand break ends. Cell, 2008, 981-994. · DOI · Paper page
- Fiorentini P, Huang KN, Tishkoff DX, Kolodner RD, Symington LS. Exonuclease I of Saccharomyces cerevisiae functions in mitotic recombination in vivo and in vitro. Mol Cell Biol, 1997, 2764-2773. · DOI · Paper page
- Bennardo N, Cheng A, Huang N, Stark JM. Alternative-NHEJ is a mechanistically distinct pathway of mammalian chromosome break repair. PLoS Genet, 2008, · DOI · Paper page
- Chu VT, Weber T, Wefers B, Wurst W, Sander S, Rajewsky K, Kühn R. Increasing the efficiency of homology-directed repair for CRISPR-Cas9-induced precise gene editing in mammalian cells. Nat Biotechnol, 2015, 543-548. · DOI · Paper page
- Robert F, Barbeau M, Éthier S, Dostie J, Pelletier J. Pharmacological inhibition of DNA-PK stimulates Cas9-mediated genome editing. Genome Med, 2015, · DOI · Paper page
- Zelensky AN, Schimmel J, Kool H, Kanaar R, Tijsterman M. Inactivation of Pol θ and C-NHEJ eliminates off-target integration of exogenous DNA. Nat Commun, 2017, · DOI
- Riesenberg S, Chintalapati M, Macak D, Kanis P, Maricic T, Pääbo S. Simultaneous precise editing of multiple genes in human cells. Nucleic Acids Res, 2019, · DOI · Paper page
- Niu H, Chung WH, Zhu Z, Kwon Y, Zhao W, Chi P, Prakash R. Mechanism of the ATP-dependent DNA end-resection machinery from Saccharomyces cerevisiae. Nature, 2010, 108-111. · DOI · Paper page
- Cejka P, Cannavo E, Polaczek P, Masuda-Sasa T, Pokharel S, Campbell JL, Kowalczykowski SC. DNA end resection by Dna2–Sgs1–RPA and its stimulation by Top3–Rmi1 and Mre11–Rad50–Xrs2. Nature, 2010, 112-116. · DOI · Paper page
- Mimitou EP, Symington LS. Sae2, Exo1 and Sgs1 collaborate in DNA double-strand break processing. Nature, 2008, 770-774. · DOI · Paper page
- Golub EI, Gupta RC, Haaf T, Wold MS, Radding CM. Interaction of human rad51 recombination protein with single-stranded DNA binding protein, RPA. Nucleic Acids Res, 1998, 5388-5393. · DOI · Paper page
- Wang X, Haber JE. Role of Saccharomyces single-stranded DNA-binding protein RPA in the strand invasion step of double-strand break repair. PLoS Biol, 2004, · DOI · Paper page
- McVey M, Khodaverdian VY, Meyer D, Cerqueira PG, Heyer WD. Eukaryotic DNA polymerases in homologous recombination. Annu Rev Genet, 2016, 393-421. · DOI · Paper page
- Liu S, Hua Y, Wang J, Li L, Yuan J, Zhang B, Wang Z. RNA polymerase III is required for the repair of DNA double-strand breaks by homologous recombination. Cell, 2021, 1314-1329.e10. · DOI
- Yang H, Wang H, Shivalila CS, Cheng AW, Shi L, Jaenisch R. One-step generation of mice carrying reporter and conditional alleles by CRISPR/Cas-mediated genome engineering. Cell, 2013, 1370-1379. · DOI · Paper page
- Zhang X, Li T, Ou J, Huang J, Liang P. Homology-based repair induced by CRISPR-Cas nucleases in mammalian embryo genome editing. Protein Cell, 2021, 316-335. · DOI
- Chen Q, Sun L, Chen ZJ. Regulation and function of the cGAS–STING pathway of cytosolic DNA sensing. Nat Immunol, 2016, 1142-1149. · DOI · Paper page
- Pawelczak KS, Gavande NS, VanderVere-Carozza PS, Turchi JJ. Modulating DNA repair pathways to improve precision genome engineering. ACS Chem Biol, 2018, 389-396. · DOI · Paper page
- Jayavaradhan R, Pillis DM, Goodman M, Zhang F, Zhang Y, Andreassen PR, Malik P. CRISPR-Cas9 fusion to dominant-negative 53BP1 enhances HDR and inhibits NHEJ specifically at Cas9 target sites. Nat Commun, 2019, · DOI · Paper page
- Song J, Yang D, Xu J, Zhu T, Chen YE, Zhang J. RS-1 enhances CRISPR/Cas9- and TALEN-mediated knock-in efficiency. Nat Commun, 2016, · DOI · Paper page
- Pinder J, Salsman J, Dellaire G. Nuclear domain ‘knock-in’ screen for the evaluation and identification of small molecule enhancers of CRISPR-based genome editing. Nucleic Acids Res, 2015, 9379-9392. · DOI · Paper page
- Rees HA, Yeh WH, Liu DR. Development of hRad51–Cas9 nickase fusions that mediate HDR without double-stranded breaks. Nat Commun, 2019, · DOI · Paper page
- Kurihara T, Kouyama-Suzuki E, Satoga M, Li X, Badawi M, Thiha M, Baig DN. DNA repair protein RAD51 enhances the CRISPR/Cas9-mediated knock-in efficiency in brain neurons. Biochem Biophysl Res Commun, 2020, 621-628. · DOI · Paper page
- Wilde JJ, Aida T, Del Rosario RCH, Kaiser T, Qi P, Wienisch M, Zhang Q. Efficient embryonic homozygous gene conversion via RAD51-enhanced interhomolog repair. Cell, 2021, 3267-3280.e18. · DOI
- Charpentier M, Khedher AHY, Menoret S, Brion A, Lamribet K, Dardillac E, Boix C. CtIP fusion to Cas9 enhances transgene integration by homology-dependent repair. Nat Commun, 2018, · DOI · Paper page
- Gutschner T, Haemmerle M, Genovese G, Draetta GF, Chin L. Post-translational regulation of Cas9 during G1 enhances homology-directed repair. Cell Rep, 2016, 1555-1566. · DOI · Paper page
- Bialk P, Rivera-Torres N, Strouse B, Kmiec EB. Regulation of gene editing activity directed by single-stranded oligonucleotides and CRISPR/Cas9 systems. PLoS ONE, 2015, · DOI · Paper page
- Olsen PA, McKeen C, Krauss S. Branched oligonucleotides induce in vivo gene conversion of a mutated EGFP reporter. Gene Ther, 2003, 1830-1840. · DOI
- van de Vrugt HJ, Harmsen T, Riepsaame J, Alexantya G, van Mil SE, de Vries Y, Bin Ali R. Effective CRISPR/Cas9-mediated correction of a Fanconi anemia defect by error-prone end joining or templated repair. Sci Rep, 2019, · DOI
- Dekker M, Brouwers C, te Riele H. Targeted gene modification in mismatch-repair-deficient embryonic stem cells by single-stranded DNA oligonucleotides. Nucleic Acids Res, 2003, 27e-27. · DOI
- Olsen PA, Randol M, Krauss S. Implications of cell cycle progression on functional sequence correction by short single-stranded DNA oligonucleotides. Gene Ther, 2005, 546-551. · DOI
- Kleinstiver BP, Pattanayak V, Prew MS, Tsai SQ, Nguyen NT, Zheng Z, Joung JK. High-fidelity CRISPR–Cas9 nucleases with no detectable genome-wide off-target effects. Nature, 2016, 490-495. · DOI · Paper page
- Slaymaker IM, Gao L, Zetsche B, Scott DA, Yan WX, Zhang F. Rationally engineered Cas9 nucleases with improved specificity. Science, 2016, 84-88. · DOI · Paper page
- Norris AL, Lee SS, Greenlees KJ, Tadesse DA, Miller MF, Lombardi HA. Template plasmid integration in germline genome-edited cattle. Nat Biotechnol, 2020, 163-164. · DOI
- Wiedenheft B, van Duijn E, Bultema JB, Waghmare SP, Zhou K, Barendregt A, Westphal W. RNA-guided complex from a bacterial immune system enhances target recognition through seed sequence interactions. Proc Natl Acad Sci USA, 2011, 10092-10097. · DOI · Paper page
- Semenova E, Jore MM, Datsenko KA, Semenova A, Westra ER, Wanner B, van der Oost J. Interference by clustered regularly interspaced short palindromic repeat (CRISPR) RNA is governed by a seed sequence. Proc Natl Acad Sci USA, 2011, 10098-10103. · DOI · Paper page
- Hsu PD, Scott DA, Weinstein JA, Ran FA, Konermann S, Agarwala V, Li Y. DNA targeting specificity of RNA-guided Cas9 nucleases. Nat Biotechnol, 2013, 827-832. · DOI · Paper page
- Chiarle R, Zhang Y, Frock RL, Lewis SM, Molinie B, Ho YJ, Myers DR. Genome-wide translocation sequencing reveals mechanisms of chromosome breaks and rearrangements in B cells. Cell, 2011, 107-119. · DOI · Paper page
- Hu J, Tepsuporn S, Meyers RM, Gostissa M, Alt FW. Developmental propagation of V(D)J recombination-associated DNA breaks and translocations in mature B cells via dicentric chromosomes. Proc Natl Acad Sci USA, 2014, 10269-10274. · DOI · Paper page
- Hu J, Zhang Y, Zhao L, Frock RL, Du Z, Meyers RM, Meng F. Chromosomal loop domains direct the recombination of antigen receptor genes. Cell, 2015, 947-959. · DOI · Paper page
- Meng FL, Du Z, Federation A, Hu J, Wang Q, Kieffer-Kwon KR, Meyers RM. Convergent transcription at intragenic super-enhancers targets AID-initiated genomic instability. Cell, 2014, 1538-1548. · DOI · Paper page
- Liu X, Liu T, Shang Y, Dai P, Zhang W, Lee BJ, Huang M. ERCC6L2 promotes DNA orientation-specific recombination in mammalian cells. Cell Res, 2020, 732-744. · DOI
- Bai W, Zhu G, Xu J, Chen P, Meng F, Xue H, Chen C. The 3′-flap endonuclease XPF-ERCC1 promotes alternative end joining and chromosomal translocation during B cell class switching. Cell Rep, 2021, · DOI
- Zuo E, Huo X, Yao X, Hu X, Sun Y, Yin J, He B. CRISPR/Cas9-mediated targeted chromosome elimination. Genome Biol, 2017, · DOI · Paper page
- Ling X, Chang L, Chen H, Gao X, Yin J, Zuo Y, Huang Y. Improving the efficiency of CRISPR-Cas12a-based genome editing with site-specific covalent Cas12a-crRNA conjugates. Mol Cell, 2021, 4747-4756.e7. · DOI
- Liu Y, Ai C, Gan T, Wu J, Jiang Y, Liu X, Lu R. Transcription shapes DNA replication initiation to preserve genome integrity. Genome Biol, 2021, · DOI
- Canela A, Maman Y, Huang SYN, Wutz G, Tang W, Zagnoli-Vieira G, Callen E. Topoisomerase II-induced chromosome breakage and translocation is determined by chromosome architecture and transcriptional activity. Mol Cell, 2019, 252-266.e8. · DOI · Paper page
- Liu X, Zhang Y, Cheng C, Cheng AW, Zhang X, Li N, Xia C. CRISPR-Cas9-mediated multiplex gene editing in CAR-T cells. Cell Res, 2017, 154-157. · DOI · Paper page
- Cho SW, Kim S, Kim Y, Kweon J, Kim HS, Bae S, Kim JS. Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases. Genome Res, 2014, 132-141. · DOI · Paper page
- Amit I, Iancu O, Levy-Jurgenson A, Kurgan G, McNeill MS, Rettig GR, Allen D. CRISPECTOR provides accurate estimation of genome editing translocation and off-target activity from comparative NGS data. Nat Commun, 2021, · DOI
- Wen W, Quan ZJ, Li SA, Yang ZX, Fu YW, Zhang F, Li GH. Effective control of large deletions after double-strand breaks by homology-directed repair and dsODN insertion. Genome Biol, 2021, · DOI
- Bothmer A, Gareau KW, Abdulkerim HS, Buquicchio F, Cohen L, Viswanathan R, Zuris JA. Detection and modulation of DNA translocations during multi-gene genome editing in T cells. CRISPR J, 2020, 177-187. · DOI · Paper page
- Karakoc E, Alkan C, O′Roak BJ, Dennis MY, Vives L, Mark K, Rieder MJ. Detection of structural variants and indels within exome data. Nat Methods, 2011, 176-178. · DOI · Paper page
- Hu J, Meyers RM, Dong J, Panchakshari RA, Alt FW, Frock RL. Detecting DNA double-stranded breaks in mammalian genomes by linear amplification–mediated high-throughput genome-wide translocation sequencing. Nat Protoc, 2016, 853-871. · DOI · Paper page
- Liu Y, Yin J, Gan T, Liu M, Xin C, Zhang W, Hu J. PEM-seq comprehensively quantifies DNA repair outcomes during gene-editing and DSB repair. STAR Protocols, 2022, · DOI
- Yin J, Liu M, Liu Y, Hu J. Improved HTGTS for CRISPR/Cas9 off-target detection. BIO-PROTOCOL, 2019, · DOI
- Yin J, Lu R, Xin C, Wang Y, Ling X, Li D, Zhang W. Cas9 exo-endonuclease eliminates chromosomal translocations during genome editing. Nat Commun, 2022, · DOI · Paper page
- Paulsen BS, Mandal PK, Frock RL, Boyraz B, Yadav R, Upadhyayula S, Gutierrez-Martinez P. Ectopic expression of RAD52 and dn53BP1 improves homology-directed repair during CRISPR–Cas9 genome editing. Nat Biomed Eng, 2017, 878-888. · DOI · Paper page
- Bieging KT, Mello SS, Attardi LD. Unravelling mechanisms of p53-mediated tumour suppression. Nat Rev Cancer, 2014, 359-370. · DOI · Paper page
- Ferguson DO, Sekiguchi JAM, Chang S, Frank KM, Gao Y, DePinho RA, Alt FW. The nonhomologous end-joining pathway of DNA repair is required for genomic stability and the suppression of translocations. Proc Natl Acad Sci USA, 2000, 6630-6633. · DOI · Paper page
- Difilippantonio MJ, Petersen S, Chen HT, Johnson R, Jasin M, Kanaar R, Ried T. Evidence for replicative repair of DNA double-strand breaks leading to oncogenic translocation and gene amplification. J Exp Med, 2002, 469-480. · DOI · Paper page
- Yan CT, Kaushal D, Murphy M, Zhang Y, Datta A, Chen C, Monroe B. XRCC4 suppresses medulloblastomas with recurrent translocations in p53-deficient mice. Proc Natl Acad Sci USA, 2006, 7378-7383. · DOI · Paper page
Cited by
p53: from understanding its structure to advances in therapeutic targeting
Wang, W., Liu, X., Liu, H., Abolhassani, H., Yan, H., Zhang, H., & Wang, X. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02549-5 · Cited by 30
Metadata
- Authors
- Yin, J., & Hu, J.
- Venue
- Acta Biochimica et Biophysica Sinica
- Published
- 2022-05-01
- Volume
- 54
- Issue
- 6
- Pages
- 767-781
- ISSN
- 1672-9145
- Cited by
- 12
- References
- 49
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.